Arcturus Therapeutics Option Alert: Nov 21 $22.5 Puts Sweep (3) near the Bid: 1000 vs 18 OI; Earnings 11/6 After Close [est] 

Arcturus Therapeutics Option Alert: Nov 21 $22.5 Puts Sweep (3) near the Bid: 1000 @ $5.424 vs 18 OI; Earnings 11/6 After Close [est] Ref=$22.39

Arcturus Therapeutics Stock (NASDAQ: ARCT)

Arcturus Therapeutics

ARCTURUS THERAPEUTICS HOLDIN

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics Holdings Inc

ARCTIC STAR EXPL CORP by Arctic Star Exploration Corp.

Arctic Star Exploration Corp

Press Releases

Arcturus Therapeutics to Attend Upcoming Investor Conferences

Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency

Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program

Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress

Small Cap

Opinion

Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth

Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. - ARCT

ARCT

AUTL

IOBT

SRPT

Abeona Therapeutics

AC Immune

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Avalo Therapeutics

Candel Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Design Therapeutics

Editas Medicine

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Eupraxia Pharmaceuticals Inc. - Common Stock

Eupraxia Pharmaceuticals

ETHZilla

Genelux

Humacyte

Immutep Limited - American Depositary Shares

Immutep

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Puma Biotechnology

PepGen

ProQR Therapeutics N.V. - Ordinary Shares

ProQR Therapeutics

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Tenaya Therapeutics

Vanda Pharmaceuticals Inc. - Common Stock

Comments

Arcturus Therapeutics

Unusual Options Activity for

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL